Zoledronic acid, pravastatin ( DrugBank: Pravastatin, Zoledronic acid )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
333	ハッチンソン・ギルフォード症候群	3

333. ハッチンソン・ギルフォード症候群

臨床試験数 : 7 / 薬物数 : 8 - (DrugBank : 3) / 標的遺伝子数 : 4 - 標的パスウェイ数 : 6

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00916747 (ClinicalTrials.gov)	August 2009	5/6/2009	Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria	An Open Label Phase II Trial of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Hutch ...	Progeria	Drug: Lonafarnib, Zoledronic Acid, and Pravastatin	Boston Children's Hospital	Schering-Plough;Merck Sharp & Dohme Corp.;Eiger BioPharmaceuticals	Active, not recruiting	N/A	N/A	All	85	Phase 2	United States
2	NCT00879034 (ClinicalTrials.gov)	March 2009	8/4/2009	A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria	A Phase II Pilot Study of Zoledronic Acid, Pravastatin, and Lonafarnib (SCH66336) for Patients With ...	Progeria;Hutchinson-Gilford Syndrome	Drug: Lonafarnib;Drug: Zoledronic Acid;Drug: Pravastatin	Boston Children's Hospital	Dana-Farber Cancer Institute;Brigham and Women's Hospital;Schering-Plough	Completed	N/A	N/A	All	5	Phase 2	United States
3	NCT00731016 (ClinicalTrials.gov)	October 2008	1/8/2008	Treatment of the Hutchinson-Gilford Progeria Syndrome With a Combination of Pravastatin and Zoledron ...	Treatment of the Hutchinson-Gilford Progeria Syndrome With a Combination of Pravastatin and Zoledron ...	Hutchinson-Gilford Progeria Syndrome	Drug: Zoledronic acid, pravastatin	Assistance Publique Hopitaux De Marseille	NULL	Completed	3 Years	N/A	Both	15	Phase 2	France

First Previous1Next Last